These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles. Tsuyuoka R, Takahashi T, Suzuki A, Sasaki Y, Nakamura K, Fukumoto M, Ohmori K, Ohno Y, Nakao K. Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248 [Abstract] [Full Text] [Related]
4. KU 812: a pluripotent human cell line with spontaneous erythroid terminal maturation. Nakazawa M, Mitjavila MT, Debili N, Casadevall N, Mayeux P, Rouyer-Fessard P, Dubart A, Roméo PH, Beuzard Y, Kishi K. Blood; 1989 May 15; 73(7):2003-13. PubMed ID: 2540861 [Abstract] [Full Text] [Related]
5. HIMeg-1, a cell line derived from a CML patient, is capable of monocytic and megakaryocytic differentiation. Cheng T, Erickson-Miller CL, Li C, Cardier J, Wang Y, Dempsey J, Mogle M, Barbera E, Murphy MJ, Dai W. Leukemia; 1995 Jul 15; 9(7):1257-63. PubMed ID: 7543177 [Abstract] [Full Text] [Related]
6. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y. Cancer Res; 1991 Jan 01; 51(1):341-8. PubMed ID: 1824823 [Abstract] [Full Text] [Related]
7. Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis. Furukawa T, Koike T, Ying W, Kishi K, Aoki S, Gotoh T, Hashimoto S, Saitoh H, Hanano M, Shinada S. Leukemia; 1994 Jan 01; 8(1):171-80. PubMed ID: 8289484 [Abstract] [Full Text] [Related]
8. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells. Kamano H, Tanaka T, Ohnishi H, Kubota Y, Ikeda K, Takahara J, Irino S, Ottalenghi S. Biochem Mol Biol Int; 1994 Aug 01; 34(1):85-92. PubMed ID: 7849628 [Abstract] [Full Text] [Related]
9. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis. Tange T, Nakahara K, Mitani K, Yamasaki I, Yasuda H, Tanaka F, Mizuguchi M, Oda H, Yatomi Y, Takanashi R. Cancer Res; 1988 Nov 01; 48(21):6137-44. PubMed ID: 3167860 [Abstract] [Full Text] [Related]
14. Immunoglobulin and T cell receptor gene rearrangements in Philadelphia chromosome-positive leukemia: a different involvement pattern in blast crisis and acute leukemia. Ohyashiki JH, Ohyashiki K, Tauchi T, Saito M, Nakazawa S, Kimura N, Toyama K. Leukemia; 1990 Aug 01; 4(8):572-9. PubMed ID: 2143795 [Abstract] [Full Text] [Related]
15. Diminished CD10, CD13, and CD15 expression in a differentiated granulocyte population in CML. Cruse JM, Lewis RE, Sanders CM, Webb RN, Beason KL, Lam J, Koehler J. Exp Mol Pathol; 2007 Oct 01; 83(2):274-6. PubMed ID: 17662271 [Abstract] [Full Text] [Related]
16. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors. Shimoda K, Okamura S, Harada N, Ikematsu W, Kondo S, Kawasaki C, Tanaka T, Etou T, Akashi K, Okamura T. Cancer Res; 1992 Jun 01; 52(11):3052-5. PubMed ID: 1534271 [Abstract] [Full Text] [Related]
17. Detection of P210bcr-abl in mature granulocytes from Ph1-positive chronic myelogenous leukemia patients by an immunoblotting method. Kuwao F, Takahashi I. Leukemia; 1993 Aug 01; 7(8):1168-73. PubMed ID: 8350617 [Abstract] [Full Text] [Related]
18. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase. Beran M, Pisa P, O'Brien S, Kurzrock R, Siciliano M, Cork A, Andersson BS, Kohli V, Kantarjian H. Cancer Res; 1993 Aug 01; 53(15):3603-10. PubMed ID: 8339266 [Abstract] [Full Text] [Related]
19. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings. Khalidi HS, Brynes RK, Medeiros LJ, Chang KL, Slovak ML, Snyder DS, Arber DA. Mod Pathol; 1998 Dec 01; 11(12):1211-21. PubMed ID: 9872654 [Abstract] [Full Text] [Related]
20. Behavior in vitro of long-term cultured bone marrow or blood cells from chronic myeloid leukemia: adhesion molecules and differentiation antigens as detected by immunocytochemistry. Pasternak G, Pasternak L. Folia Biol (Praha); 1994 Dec 01; 40(6):439-54. PubMed ID: 7589702 [Abstract] [Full Text] [Related] Page: [Next] [New Search]